NCT03500796View on ClinicalTrials.gov

Combined Amniotic Membrane and Platelet Rich Plasma Clot for Management of Central Corneal Perforation

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 15, 2018

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Corneal Perforation
Interventions
PROCEDURE

Platelet rich plasma clot implantation

Implantation of a platelet rich plasma clot, which is created from the plasma of the patients, and refrigerated to be inserted under the sealing amniotic membrane

PROCEDURE

Wound closure with amniotic membrane

Closure of the corneal perforation with a synthetic amniotic membrane with a 2 mm safety margin

Trial Locations (1)

Unknown

Faculty of Medicine, Minya

All Listed Sponsors
lead

Minia University

OTHER

NCT03500796 - Combined Amniotic Membrane and Platelet Rich Plasma Clot for Management of Central Corneal Perforation | Biotech Hunter | Biotech Hunter